Patients With Acute Myeloid Leukemia and RAS Mutations...

Patients With Acute Myeloid Leukemia and RAS Mutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study

Neubauer, A., Maharry, K., Mrozek, K., Thiede, C., Marcucci, G., Paschka, P., Mayer, R. J., Larson, R. A., Liu, E. T., Bloomfield, C. D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2007.14.0418
Date:
October, 2008
File:
PDF, 175 KB
english, 2008
Conversion to is in progress
Conversion to is failed